Location: Home
  • search
  • go
  • Relate News
  • 4/1/2023China Further Intensifies Healthcare Cost Containment and Price Contro...
  • 3/29/2023Investing in China's Healthcare Sector (China Briefing)
  • 3/15/2023Deloitte: 2023 China LSHC Investment and M&A Market Outlook
  • 3/9/2023PhIIC: Chinese Retail Pharmacy Sales Fell Sharply in 2022 Despite Rebo...
  • 2/24/2023SMEI: Chinese Pharma Revenues Down 1.6% Last Year But Expected to Rebo...
  • 2/24/2023IQVIA: Chinese Hospital Drug Market Shrank 2.1% in 2022
  • 2/16/2023IQVIA: Chinese Pharma to See 2%-5% CAGR Before 2027
  • 2/10/2023China Drug Sales Performance of Top Seven MNC Pharma Cos in 2022
  • 2/2/2023Performance of A Share-listed MedPharm Cos Mixed in 2022
  • 2/1/2023NH Reports on Chinese OTC Sleep Aids Market in MAT 09/2022
  • 2/1/2023NH Reports on Chinese OTC Eye Care Market in MAT 09/2022
  • 1/24/2023China's Drug-Pricing Policy Impedes Biotech Profits (Financial Times)
  • 1/16/2023The China Imperative for Multinational Companies
  • 1/13/2023HSMAP: Chinese MedPharm Industry Operations Report 2022
  • 1/13/2023PhIRDA: Early Stage Financing and Recent Startups Dominate Chinese Pha...
  • 1/9/2023Big Pharma Preferred by Foreign Investors as China Reopens, Appetite F...
  • 11/24/2022IQVIA: Chinese Hospital Drug Market Steady in MAT Q3/2022
  • 11/23/2022GlobalData: Chinese Manufacturers' Transition to Innovative Pharma Req...
  • 11/21/2022Performance of A Share-listed MedPharm Cos Improved in Q3/2022
  • 11/11/2022Review of A Share-listed Chinese MedPharm Cos in Q3/2022
  • 11/10/2022China's Biopharma Industry: Market Prospects, Investment Paths (China ...
  • 11/10/2022Under Geopolitics and Market Rout, Chinese Biotechs Center on Data Qua...
  • 10/18/2022China's Party Congress Promises Continuity, Not Change (AP)
  • 10/18/2022Xi's Work Report to the 20th Party Congress: 5 Takeaways (The Diplomat...
  • 10/16/2022SMEI: Chinese Terminal Drug Market Growth Slowed to 1.7% in H1/2022
  • 10/2/2022NH Reports MAT H1/2022 Data on the Chinese Cough, Cold and Allergy Mar...
  • 9/28/2022MNCs Witnessed China Performance Slump in Q2/2022
  • 9/14/2022MIIT: China to Further Optimize Industrial Chain for Pharmaceutical Se...
  • 9/7/2022Vision Forward Remains Blurry for Chinese Economy and Healthcare Secto...
  • 9/6/2022A Share-Listed Chinese Pharma Cos Report Performance in H1/2022
  • Page:4/22 Total number of articles:649: [First][<<] [2] [3] [4] [5] [6] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group